News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
285,014 Results
Type
Article (11067)
Company Profile (85)
Press Release (273862)
Section
Business (83777)
Career Advice (311)
Deals (16560)
Drug Delivery (50)
Drug Development (29237)
Employer Resources (52)
FDA (7519)
Job Trends (7032)
News (138170)
Policy (11257)
Tag
2024 BioCapital Digital (1)
2024 BioForest Digital (5)
2024 BioForest Standard (1)
2024 BioMidwest Standard (2)
2024 Bio NC Digital (4)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (5)
2024 Biotech Beach Digital (2)
2024 Biotech Beach Standard (3)
2024 Genetown Standard (4)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Digital (3)
2024 Pharm Country Standard (5)
2025 Lone Star Bio Digital (1)
2026 BioCapital Elite (1)
2026 BioMidwest Elite (2)
2026 Biotech Bay Elite (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (1)
Academia (943)
Academic (1)
Allergies (36)
Alliances (23750)
ALS (32)
Alzheimer's disease (591)
Antibody-drug conjugate (ADC) (57)
Approvals (7598)
Artificial intelligence (138)
Autoimmune disease (7)
Automation (7)
Bankruptcy (78)
Best Places to Work (6142)
BIOSECURE Act (11)
Biosimilars (60)
Biotechnology (42)
Bladder cancer (31)
Brain cancer (5)
Breast cancer (123)
Cancer (1004)
Cardiovascular disease (89)
Career advice (274)
Career pathing (7)
CAR-T (55)
Cell therapy (188)
Cervical cancer (13)
Clinical research (25224)
Collaboration (520)
Compensation (195)
Complete response letters (5)
COVID-19 (1288)
CRISPR (18)
C-suite (132)
Cystic fibrosis (36)
Data (1045)
Denatured (15)
Depression (20)
Diabetes (120)
Diagnostics (3251)
Digital health (12)
Diversity (4)
Diversity, equity & inclusion (15)
Drug discovery (50)
Drug pricing (19)
Drug shortages (12)
Duchenne muscular dystrophy (34)
Earnings (28972)
Editorial (12)
Employer branding (10)
Employer resources (46)
Events (46260)
Executive appointments (413)
FDA (8129)
Featured Employer (22)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (1)
Funding (336)
Gene editing (45)
Generative AI (13)
Gene therapy (135)
GLP-1 (316)
Government (1351)
Grass and pollen (2)
Guidances (27)
Healthcare (8145)
Huntington's disease (2)
IgA nephropathy (16)
Immunology and inflammation (39)
Indications (21)
Infectious disease (1366)
Inflammatory bowel disease (68)
Inflation Reduction Act (1)
Influenza (26)
Intellectual property (54)
Interviews (37)
IPO (7566)
IRA (9)
Job creations (1257)
Job search strategy (253)
Kidney cancer (4)
Labor market (6)
Layoffs (151)
Leadership (4)
Legal (1878)
Liver cancer (36)
Lung cancer (183)
Lymphoma (68)
Machine learning (2)
Management (13)
Manufacturing (176)
MASH (35)
Medical device (6823)
Medtech (6827)
Mergers & acquisitions (9347)
Metabolic disorders (295)
Multiple sclerosis (31)
NASH (11)
Neurodegenerative disease (26)
Neuropsychiatric disorders (5)
Neuroscience (802)
NextGen: Class of 2025 (1913)
Non-profit (1756)
Northern California (1144)
Now hiring (11)
Obesity (150)
Opinion (55)
Ovarian cancer (30)
Pain (25)
Pancreatic cancer (39)
Parkinson's disease (60)
Partnered (10)
Patents (83)
Patient recruitment (55)
Peanut (23)
People (27734)
Pharmaceutical (32)
Pharmacy benefit managers (1)
Phase I (6005)
Phase II (9973)
Phase III (11098)
Pipeline (592)
Podcasts (22)
Policy (36)
Postmarket research (993)
Preclinical (1797)
Press Release (54)
Prostate cancer (46)
Psychedelics (10)
Radiopharmaceuticals (142)
Rare diseases (149)
Real estate (2788)
Recruiting (21)
Regulatory (9009)
Reports (19)
Research institute (1015)
Resumes & cover letters (35)
Rett syndrome (2)
RNA editing (1)
RSV (21)
Schizophrenia (33)
Series A (62)
Series B (41)
Service/supplier (4)
Sickle cell disease (30)
Southern California (979)
Special edition (4)
Spinal muscular atrophy (92)
Sponsored (19)
Startups (1235)
Stomach cancer (8)
Supply chain (39)
The Weekly (7)
United States (10223)
Vaccines (369)
Venture capitalists (11)
Webinars (8)
Weight loss (85)
Women's health (15)
Worklife (1)
Date
Today (67)
Last 7 days (348)
Last 30 days (1423)
Last 365 days (17569)
2025 (4342)
2024 (18155)
2023 (20026)
2022 (29051)
2021 (30822)
2020 (28647)
2019 (20921)
2018 (15748)
2017 (14336)
2016 (13430)
2015 (15182)
2014 (10923)
2013 (8757)
2012 (9416)
2011 (8988)
2010 (7734)
Location
Africa (313)
Alabama (13)
Alaska (4)
Arizona (60)
Arkansas (6)
Asia (22037)
Australia (3562)
California (2585)
Canada (862)
China (400)
Colorado (95)
Connecticut (103)
Delaware (86)
Europe (46287)
Florida (367)
Georgia (95)
Hawaii (1)
Idaho (16)
Illinois (216)
India (22)
Indiana (204)
Iowa (4)
Japan (120)
Kansas (30)
Kentucky (5)
Louisiana (3)
Maine (28)
Maryland (329)
Massachusetts (2082)
Michigan (156)
Minnesota (162)
Mississippi (1)
Missouri (50)
Montana (15)
Nebraska (7)
Nevada (23)
New Hampshire (49)
New Jersey (961)
New Mexico (14)
New York (790)
North Carolina (490)
North Dakota (6)
Northern California (1144)
Ohio (110)
Oklahoma (5)
Oregon (10)
Pennsylvania (623)
Puerto Rico (6)
Rhode Island (13)
South America (467)
South Carolina (5)
Southern California (979)
Tennessee (43)
Texas (302)
Utah (53)
Virginia (59)
Washington D.C. (26)
Washington State (224)
West Virginia (1)
Wisconsin (23)
285,014 Results for "kelyniam global".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
KELYNIAM ACHIEVES RECORD REVENUE & PROFITABILITY FOR 2024
March 17, 2025
·
2 min read
Press Releases
Kelyniam Corporate Update
January 21, 2025
·
2 min read
Press Releases
Kelyniam Global, Inc., (“KLYG”) Announces Private Investment to Public Entity (“PIPE”) Closure of Securities Offering
December 16, 2024
·
2 min read
Press Releases
Kelyniam Global Releases Q3 Financials, Strong Performance Continues
November 11, 2024
·
2 min read
Business
Kelyniam Global Releases 3rd Quarter 2023 Financials
Kelyniam Global, a maker of custom cranial implants, announced results for its third quarter ended September 30, 2023.
December 21, 2023
·
2 min read
Business
Strong Fourth Quarter Powers 2023 Kelyniam Financials
Kelyniam Global, a maker of custom cranial implants, announced results for its year ended December 31, 2023.
March 16, 2024
·
2 min read
Business
Kelyniam Global Releases 2nd Quarter 2023 Financials
Kelyniam Global, a maker of custom cranial implants, announced results for its half year ended June 30, 2023.
August 14, 2023
·
2 min read
Business
Kelyniam Global Releases Q1 Financials, Announces Licensing Agreement with Bioplate for Osteopore Products
Kelyniam Global, a leading maker of custom cranial implants, announced results for its quarter ended March 31, 2023.
May 22, 2023
·
3 min read
Genetown
Kelyniam Global Announces Record Sales of $3 million in 2022 Financial Statements
Kelyniam Global, a maker of custom cranial implants, announced results for its year ended December 31, 2022.
March 16, 2023
·
2 min read
Business
Kelyniam Global Announces 3rd Quarter Results
Kelyniam Global, a maker of custom cranial implants, announced results for its quarter ended September 30, 2022.
November 15, 2022
·
2 min read
1 of 28,502
Next
